Page 3 - General Plastic News Today

In the institution decision for Mylan Pharmaceuticals Inc. v. Regeneron Pharmaceuticals, Inc., IPR2022-01225, Paper 21 (P.T.A.B. Jan. 11, 2023), the Patent Trials & Appeals Board ("the Board")...

2022 was a milestone year for the Patent Trial and Appeal Board. In April, Kathi Vidal began her tenure as Director of the United States Patent and Trademark Office with an early focus...

The latest instalment of the IAM-Docket Navigator US patent litigation special report puts the magnifying glass to data on discretionary denials

I enjoy all aspects of patent law and am always happy to get involved in all kinds of different matters, ranging from district court and ITC litigation, to PTAB proceedings.

The ongoing battle over the proper remedy for Patent Trial and Appeal Board (PTAB) petitioner misconduct took a dramatic turn this past week.

Jessica recently joined Arnold & Porter's IP practice in March 2022 after more than seven years as an administrative patent judge (APJ) with the Patent Trial and Appeal Board (PTAB).

New details have come to light in a dispute over allegations of gamesmanship in inter partes reviews filed by two third-party challengers, OpenSky Industries and Patent Quality Assurance, against VLSI Technology LLC.

In the precedential decision Gen. Plastic Indus. Co. v. Canon Kabushiki Kaisha, IPR2016-01357, Paper 19 (PTAB Sept. 6, 2017), the PTAB articulated seven non-exclusive factors to be...

In the precedential decision Gen. Plastic Indus. Co. v. Canon Kabushiki Kaisha, IPR2016-01357, Paper 19 (PTAB Sept. 6, 2017), the PTAB articulated seven non-exclusive factors to be considered...

Exercising its discretion under 35 U.S.C. § 314(a), the Patent Trial & Appeal Board (Board) denied institution of two inter partes reviews (IPRs) based on its understanding of its own precedential 2017 decision...